Stem Cell Meetings & Conferences 2013

Top stem cell meetings and conferences. If you want me to post your meeting, email me or post a comment (I’ll delete the comment and add the meeting to the main page).

Meetings from 2012 can be found here.

My listing of these meetings is not an endorsement of them, but is provided for informational purposes.

2013 

CSHL Stem Cell Biology, Sept. 24-28

Stem Cells & Regenerative Medicine Congress, Cambridge MA, Sept. 30-Oct. 1

Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM), Berlin Germany, Oct. 10-13.

Regener8 Annual Conference, Leeds, UK, Oct. 10

The 2013 Till and McCulloch Meeting (formerly the Canadian Stem Cell Network’s AGM)  in Banff October 22-25th

Stem Cell Meeting on the Mesa, La Jolla, CA October 14-16

NYSCF Annual Meeting, New York, NY, Oct 16-17.

2013 San Antonio Nathan Shock Center Conference on Aging: Stem Cells and Aging, San Antonio, Texas, October 17-20

Stem Cell Congress, London, November 4-5

Using Stem Cells to Model and Treat Human Disease (Cell Symposia), LA, CA USA Nov. 21-23.

World Stem Cell Summit San Diego, CA December 4-6

 

Meetings from earlier in 2013

Scale-Up and Manufacturing of Cell-Based Therapies II.  An ECI Conference Series.   San Diego, California, USA  January 21-23

Stem Cell Summit New York. NY, NY. Feb. 19. 

Keystone Symposia: Stem Cell Regulation in Homeostasis and Disease, Banff, AB Canada  
Feb. 24 – March 1

Human Pluripotent Stem Cells: Progress to Therapy, University of Sheffield, UK April 8-10

Vatican Stem Cell Meeting (Adults only), April 11-13

Gordon Conference Stem Cells & Cancer, Les Diablerets, Switzerland April 21-26

First Annual Israeli Meeting of translational research on stem cells, cell therapy and regenerative medicine in industry and academia, Conference and Exhibition – Israstem 2013, Ramat Gan, Israel, April 22-23

The Next Gen Stem Cell Conference, Saratoga, NY, May 8-9.

Stem Cell Event Trilogy, London, June 4-6

The Orthobiologic Institute (TOBI) 4th Annual PRP & Regenerative Medicine Symposium with Cadaver Lab, Los Angeles, June 7-8, 2013

New Avenues for Brain Repair: Programming and Reprogramming the Central Nervous System, Harvard, June 10-11

ISSCR Annual Meeting, Boston, June 12-15

CSHL Course Mouse Development, Stem Cells & Cancer, June 5 – 25

Neural Stem Cell Institute Annual Stem Cell Soiree, Saratoga Springs, NY, July 17.

MSC 2013: Adult Stem Cell Therapy & Regenerative Medicine, Cleveland OH,  August 19th – August 21st

Stem Cells & Cell Therapy Business Summit, London England, Sept. 5-6.

ISSCR Regional Forum: Stem Cells In Translation, Florence Italy, Sept. 15-18.

16 thoughts on “Stem Cell Meetings & Conferences 2013”

  1. Paul, thank you for answering the question. Jenny and I worked relentlessly at the Texas State Capitol. Some of our priority issues have taken several sessions to enact into law. Since our MS diagnosis, we have made it a personal mission to advocate on behalf of those living with chronic disease, providing a positive voice for the patients. Our efforts have never been MS specific. With your expertise in regulations/ethics/stem cells as well as being a cancer survivor, we know you have a very clear understanding of what happens when faced with a life altering illness. We would like to approach you with the idea of assisting us in influencing change for last hope chronic patients. As a result of current regulations we find ourselves no longer able to seek treatment in the US. How can we move forward and where do we start to persuade revisions? In your opinion, can any of the regulations be modified to accommodate those out of time? The field of regenerative medicine is rapidly advancing. Do the regulations need to adjust as well? It seems there is a group of last hope patients who do not have time and are left without options. Has this ever been addressed? Do current regulations accommodate this situation? How would we go about influencing awareness and change? I would love to relay this to Mr. Turner as well. I am not good on Twitter as I am very long winded with my responses.:) I find it very difficult to provide a full understanding of our intent with such limited text. Jenny and I joke frequently as laughter is the best medicine. Sorry about the Bon QuiQui reference regarding your “complicated” order. We couldn’t resist. We joke, however we take our mission very seriously. Have you ever been approached with opening a positive dialogue to try and work together to find common ground to address these needs? Both you and Mr. Turner are respected in your field. We realize we have to start somewhere and simply would like direction as well as an opportunity to develop allies in moving forward. We may not agree 100% on every issue, but working together makes sense in finding a feasible resolution. If you prefer to speak via email, you can reach me at tracyt41@gmail.com. We still have so much to learn and have only recently heard of the Dec. of Helsinki. Are there avenues we have not utilized at this point? We realize the importance of starting somewhere. We believe in moving forward in a positive manner with hopes of making sure all avenues have been researched. We respect current regulations, however how do we move forward and could these regulations be looked at? I know I have posed several questions. Thank you for your time and consideration.

  2. Mr. Paul Knoepfler, I noted at the Stem Cell Summit in Houston, Tx. that the Article 35 of the Declaration of Helsinki was discussed during some of the presentations, and again during the patient panel discussion, what exactly is your take on this document, and why is it being ignored for patients in my particular situation. Who signed this document representing the USA? (I’m a CellTex MS patient) Thanks for your time and expertise. 🙂

    1. Hi Jennifer,
      You can just call me “Paul”.
      The Article 35 of the Helsinki Declaration is controversial as is the document as a whole. Respected organizations such as the AMA and others in the U.S. have not outright accepted it. I believe that some MDs use it as a justification for risky procedures that have little scientific backing and yet they charge patients at the same time.

  3. The 2013 Till and McCulloch Meeting will be held in Banff from October 22-25th (formerly the Canadian Stem Cell Network’s AGM)

  4. You forgot the Second Midwest Conference on Stem Cell Biology and Therapy going on at the moment at Oakland University in Michigan.

Leave a Reply